These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 6982243)
1. Properties and specificity of binding sites for the immunomodulator bestatin on the surface of mammalian cells. Müller WE; Schuster DK; Zahn RK; Maidhof A; Leyhausen G; Falke D; Koren R; Umezawa H Int J Immunopharmacol; 1982; 4(5):393-400. PubMed ID: 6982243 [TBL] [Abstract][Full Text] [Related]
2. Identification and properties of the cell membrane bound leucine aminopeptidase interacting with the potential immunostimulant and chemotherapeutic agent bestatin. Leyhausen G; Schuster DK; Vaith P; Zahn RK; Umezawa H; Falke D; Müller WE Biochem Pharmacol; 1983 Mar; 32(6):1051-7. PubMed ID: 6838651 [TBL] [Abstract][Full Text] [Related]
3. Use of azidobestatin as a photoaffinity label to identify the active site peptide of leucine aminopeptidase. Taylor A; Peltier CZ; Jahngen EG; Laxman E; Szewczuk Z; Torre FJ Biochemistry; 1992 Apr; 31(16):4141-50. PubMed ID: 1567860 [TBL] [Abstract][Full Text] [Related]
4. The slow, tight binding of bestatin and amastatin to aminopeptidases. Wilkes SH; Prescott JM J Biol Chem; 1985 Oct; 260(24):13154-62. PubMed ID: 2865258 [TBL] [Abstract][Full Text] [Related]
5. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems. Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322 [TBL] [Abstract][Full Text] [Related]
6. Mitogenic effect of bestatin on lymphocytes. Ishizuka M; Sato J; Sugiyama Y; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1980 Jun; 33(6):653-62. PubMed ID: 7419476 [TBL] [Abstract][Full Text] [Related]
7. Bestatin, an inhibitor of aminopeptidase B, suppresses the proliferation and differentiation of human B-cells in vitro. Morikawa K; Morikawa S; Nakano A; Oseko F Int J Immunopharmacol; 1989; 11(8):905-13. PubMed ID: 2613395 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of bovine lens leucine aminopeptidase by bestatin: number of binding sites and slow binding of this inhibitor. Taylor A; Peltier CZ; Torre FJ; Hakamian N Biochemistry; 1993 Jan; 32(3):784-90. PubMed ID: 8422382 [TBL] [Abstract][Full Text] [Related]
9. Mitogenic potentials of bestatin, amastatin, arphamenines A and B, FK-156 and FK-565 on spleen lymphocytes. Weissmann N; Leyhausen G; Maidhof A; Tanaka W; Umezawa H; Müller WE J Antibiot (Tokyo); 1985 Jun; 38(6):772-8. PubMed ID: 4019321 [TBL] [Abstract][Full Text] [Related]
10. Bestatin, a stimulator of polysome assembly in T cell lymphoma (L 5178y). Muller WE; Zahn RK; Maidhof A; Schroder HC; Umezawa H Biochem Pharmacol; 1981 Dec; 30(24):3375-7. PubMed ID: 7326051 [No Abstract] [Full Text] [Related]
11. Inhibition of fiber cell globulization and hyperglycemia-induced lens opacification by aminopeptidase inhibitor bestatin. Chandra D; Ramana KV; Wang L; Christensen BN; Bhatnagar A; Srivastava SK Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2285-92. PubMed ID: 12091429 [TBL] [Abstract][Full Text] [Related]
12. Induction of DNA polymerase alpha and terminal deoxynucleotidyl transferase in the human lymphoblastoid cell line Molt-4 by the immunomodulator bestatin. Leyhausen G; Dippold W; Zahn RK; Meyer zum Büschenfelde KH; Umezawa H; Müller WE Immunopharmacology; 1984 Jun; 7(3-4):151-7. PubMed ID: 6590537 [TBL] [Abstract][Full Text] [Related]
13. An aminopeptidase inhibitor, bestatin, enhances progesterone and oestradiol secretion by porcine granulosa cells stimulated with follicle stimulating hormone in vitro. Tachibana T; Fujiwara H; Suginami H; Nakamura K; Honda T; Yamada S; Maeda M; Mori T Hum Reprod; 1996 Mar; 11(3):497-502. PubMed ID: 8671253 [TBL] [Abstract][Full Text] [Related]
14. Immunochemical identification of the cell surface bound leucine aminopeptidase, the target enzyme for the immunostimulant bestatin. Leyhausen G; Gramzow M; Zahn RK; Steffen R; Umezawa H; Müller WE J Antibiot (Tokyo); 1983 Jun; 36(6):728-34. PubMed ID: 6348011 [TBL] [Abstract][Full Text] [Related]
15. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes. Schorlemmer HU; Bosslet K; Sedlacek HH Cancer Res; 1983 Sep; 43(9):4148-53. PubMed ID: 6871856 [TBL] [Abstract][Full Text] [Related]
16. Aminopeptidase inhibitor ubenimex (bestatin) inhibits the growth of human choriocarcinoma in nude mice through its direct cytostatic activity. Inoi K; Goto S; Nomura S; Isobe K; Nawa A; Okamoto T; Tomoda Y Anticancer Res; 1995; 15(5B):2081-7. PubMed ID: 8572606 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of a membrane-bound enkephalin-degrading aminopeptidase by bestatin analogs. Shimamura M; Hazato T; Hachisu M; Katayama T J Neurochem; 1984 Sep; 43(3):888-90. PubMed ID: 6431055 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of arginine aminopeptidase by bestatin and arphamenine analogues. Evidence for a new mode of binding to aminopeptidases. Harbeson SL; Rich DH Biochemistry; 1988 Sep; 27(19):7301-10. PubMed ID: 3207677 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of sulfur-containing analogues of bestatin. Inhibition of aminopeptidases by alpha-thiolbestatin analogues. Ocain TD; Rich DH J Med Chem; 1988 Nov; 31(11):2193-9. PubMed ID: 3184126 [TBL] [Abstract][Full Text] [Related]
20. Increased sensitivity of IL2-dependent cultured T cells and enhancement of in vitro IL2 production by human lymphocytes treated with Bestatin. Noma T; Klein B; Cupissol D; Yata J; Serrou B Int J Immunopharmacol; 1984; 6(2):87-92. PubMed ID: 6429060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]